Pharmacokinetics of Valacyclovir Oral Solution in Children

clinical trial

Details

Instance of: clinical trial
Start time: 30 September 2019
End time: 1 September 2020
Country: Netherlands
Main subject: herpes simplex, herpes zoster, chickenpox
maximum age: 12
minimum age: 2
number of participants: 16
research intervention: valacyclovir
short name: VALID2
study type: interventional study
title: Pharmacokinetics of a New Paediatric Formulation of Valacyclovir Used for Prophylaxis and Treatment of Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV) Infections in Children, Phase II (VALID II)

Nothing in the MetaHistoryBook collection references this item yet.